Don’t miss the latest developments in business and finance.

Rheumatoid Arthritis

Rheumatoid arthritis mainly influences the joints, causing pain, inflammation, and stiffness usually in body parts such as the fingers, ankles, feet, hands, wrists, knees, and toes

Updated On: 02 Feb 2024 | 11:49 AM IST

BBL launched Hulio, a biosimilar version of Abbvie's blockbuster drug Humira, in the US in July

Updated On: 22 Dec 2023 | 5:55 PM IST

Study will begin in May, to take two years to complete

Updated On: 23 Mar 2022 | 7:02 PM IST

Drug firm Lupin on Wednesday said it has launched generic Duexis tablets used to treat the symptoms of rheumatoid arthritis and osteoarthritis in the US market.

Updated On: 15 Sep 2021 | 4:09 PM IST

The study, published in the journal Annals of the Rheumatic Diseases, linked treatment of RA with improvements in vascular stiffness -- an indicator of CVD

Updated On: 05 Sep 2020 | 6:24 PM IST

Drug maker Lupin on Wednesday said it has launched Leflunomide tablets, used to treat rheumatoid arthritis, in the US market. The company has launched the product in 10 mg and 20 mg strengths after receiving the approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a statement. The product would be manufactured at drug maker's Pithampur (Unit I) facility in Madhya Pradesh, it added. The Mumbai-based company's product is the generic equivalent of Sanofi-Aventis US LLC's Arava tablets and is indicated for the treatment of adults with active rheumatoid arthritis (RA). As per IQVIA MAT June data, Leflunomide tablets had an annual sales of around USD 42 million in the US.

Updated On: 02 Sep 2020 | 6:04 PM IST

HCQ was dropped from the solidarity trial that WHO was conducting as a part of a global effort in May.

Updated On: 05 Jun 2020 | 10:59 AM IST

Eating fish may help reduce joint pain and swelling of rheumatoid arthritis

Updated On: 24 Jun 2017 | 11:09 PM IST